Symbol="CLRB"
AssetType="Common Stock"
Name="Cellectar Biosciences Inc"
Description="Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development and commercialization of drugs for the treatment of cancer. The company is headquartered in Florham Park, New Jersey."
CIK="1279704"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="3301 AGRICULTURE DRIVE, MADISON, WI, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="15877000"
EBITDA="-31231272"
PERatio="None"
PEGRatio="0"
BookValue="0.611"
DividendPerShare="0"
DividendYield="0"
EPS="-4.12"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.838"
ReturnOnEquityTTM="-1.797"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-4.12"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="12.6"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="1.271"
EVToRevenue="-"
EVToEBITDA="0.0643"
Beta="1.323"
num_52WeekHigh="6.42"
num_52WeekLow="1.25"
num_50DayMovingAverage="1.87"
num_200DayMovingAverage="1.692"
SharesOutstanding="9740500"
DividendDate="2018-07-17"
ExDividendDate="None"
symbol="CLRB"
open="1.57"
high="1.67"
low="1.57"
price="1.63"
volume="18718.00"
latest_trading_day="2023-08-14"
previous_close="1.60"
change="0.03"
change_percent="1.8750%"
aroon_positive_momentum_days="52"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="52"
Volume_recent_avg="32743"
Change_recent_avg="0.01"
Delta_recent_avg="0.1"
Variance_recent_avg="0.05"
Change_ratio_recent_avg="-0.21"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="52"
Aroon_momentum_negative="48"
image_negative_thumbnail_id_1="507"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0098.jpeg"
image_negative_thumbnail_id_2="1094"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0127.jpeg"
image_neutral_thumbnail_id_1="558"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0041.jpeg"
image_neutral_thumbnail_id_2="596"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0003.jpeg"
image_positive_thumbnail_id_1="951"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0113.jpeg"
image_positive_thumbnail_id_2="672"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0036.jpeg"
image_professor_thumbnail_id_1="1204"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0038.jpeg"
image_professor_thumbnail_id_2="1187"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0021.jpeg"
